We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Anticancer Therapies – Products

Cell Therapy
Whitepaper

Advances in Cell Therapy

This article examines recent advancements in cell therapy research, from promising lab findings poised for clinical translation to enhancements in development, testing, and manufacturing processes.
Improving Cancer Patient Care With Professor Mark Lawler
Whitepaper

Improving Cancer Patient Care With Professor Mark Lawler

In this article, Mark Lawler, professor of digital health, answers your questions about these revolutionary techniques and discusses the barriers to their implementation in the clinic. Prof. Lawler has an international reputation in cancer research and a focus on developing a molecular understanding of cancer to improve patient care, including through precision medicine.
Advanced Oncology Treatment Candidates Developed With Next-Generation Preclinical Models
Whitepaper

Advanced Oncology Treatment Candidates Developed With Next-Generation Preclinical Models

One factor that can significantly impact the success of oncology drug development is the preclinical model used. The right model can provide valuable insights into key interactions within the body and help researchers to better understand how tumors respond to treatment.
Novel CAR Technology To Transform Cancer Therapy
Whitepaper

Novel CAR Technology To Transform Cancer Therapy

Chimeric antigen receptor (CAR) therapies involve the use of engineered receptors capable of redirecting immune cells to recognize and destroy cancer cells expressing a specific antigen. Currently, CAR T cells dominate the field of CAR therapy.
Media in a 12 well plate.
Product News

InSphero To Revolutionize Oncology Research Through Advanced 3D Cell-Based Assays With ATCC

InSphero, and ATCC, will work together to introduce new paradigms in the rapidly evolving field of 3D cell-based oncology research.
A lab worker pipetting a solution onto a plate.
Product News

FDA Grants Fast Track Designation to SonALAsense’s SONALA-001

Encouraging preliminary data from the ongoing DIPG clinical study to be presented at the 2023 Society for Neuro-Oncology Annual Meeting in Vancouver.
Cancer cells.
Product News

Xsphera Biosciences and NEX-I Collaborate To Advance Oncology Drug Research

Xsphera Biosciences, is pleased to announce the formalization of a Memorandum of Understanding (MOU) with NEX-I, a Seoul-based pioneer in immune-oncology therapeutics.
Unlocking the Potential of Cancer Immunotherapy with 3D Immune Cell Killing Assays
Whitepaper

Unlocking the Potential of Cancer Immunotherapy with 3D Immune Cell Killing Assays

This literature review explores the latest in 3D immune cell killing assays for cancer immunotherapy research.
Antibodies.
Product News

Lonza Further Extends Collaboration With Major Biopharmaceutical Partner for Manufacturing Antibody-Drug Conjugates

Extended long-term collaboration to provide significant additional bioconjugation capacity for commercialization of antibody-drug conjugates (ADCs) for use against hard-to-treat cancers.
Cancer cells.
Product News

CELLINK & Carcinotech Partner to Personalize Cancer Drug Development

Carcinotech and CELLINK plan to revolutionize the drug discovery market by leveraging CELLINK’s bioprinting solutions and Carcinotech’s expertise in producing 3D bioprinted living tumors to provide protocols for users to develop cutting-edge cancer models.
Advertisement